- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01625585
Single Balloon Enterosocpy Obscure Gastrointestinal Bleeding Bleed
October 14, 2013 updated by: Washington University School of Medicine
LONG-TERM OUTCOMES AFTER SINGLE-BALLOON ENTEROSCOPY IN PATIENTS WITH OBSCURE GASTROINTESTINAL BLEEDING
The goal of the present study is to investigate the clinical outcomes of patients with gastrointestinal bleeding originating from the small intestine following diagnostic investigation with single balloon enteroscopy.
We hypothesize that single balloon enteroscopy can arrive at a diagnosis and provide therapeutics in a majority of patients with gastrointestinal bleeding originating in the small intestine.
Study Overview
Status
Completed
Conditions
Detailed Description
The small intestine has been, until recent years, a black box to gastroenterologists because it is difficult to see and reach.
Radiological imaging provides little details of small intestinal mucosa.
Capsule endoscopy, introduced in 2001, enables gastroenterologists to visualize the entire small intestine from within for the first time, but it is only a diagnostic tool.
Single-balloon enteroscopy (SBE) is a new enteroscopy methods that use an overtube with one balloon or a spiral to help pleat bowel onto the endoscope and allow examination of the distal small bowel.
This methods allow for biopsy, hemostasis, and other therapeutic interventions to be performed in the small bowel.
Early reports have been promising; with 50-70% diagnostic yield for small bowel pathology reported in the literature.
However, despite these promising results the impact SBE findings on patient outcomes is not clear.
Study Type
Observational
Enrollment (Actual)
147
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Barnes Jewish Hospital/ Washington University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients who underwent SBE at Washington University Medical Center/ Barnes Jewish Hospital prior to 1/1/2011 were eligible for inclusion.
There was no control group as this was a retrospective cohort study.
Description
Inclusion Criteria:
- Patients with Obscure Gastrointestinal Bleeding undergoing SBE at Barnes Jewish Hospital
Exclusion Criteria:
- Less than 3 months of follow up after SBE
- The endoscope could not be advanced into the duodenum will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Consecutive patients undergoing SBE for OGIB
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recurrence of obscure gastrointestinal bleeding following single balloon enteroscopy
Time Frame: 4 years
|
The primary outcome is recurrence of gastrointestinal bleeding, defined as recurrent overt or occult gastrointestinal bleeding, hospitalization for gastrointestinal bleeding or acute blood loss anemia.
|
4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
June 19, 2012
First Submitted That Met QC Criteria
June 19, 2012
First Posted (Estimate)
June 21, 2012
Study Record Updates
Last Update Posted (Estimate)
October 16, 2013
Last Update Submitted That Met QC Criteria
October 14, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBEWashU 2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obscure Gastrointestinal Bleeding
-
Brigham and Women's HospitalWithdrawnObscure Gastrointestinal BleedingUnited States
-
Washington University School of MedicineTerminatedObscure Gastrointestinal BleedingUnited States
-
King Chulalongkorn Memorial HospitalCompletedOvert Obscure Gastrointestinal BleedingThailand
-
University of Southern CaliforniaCompletedObscure Gastrointestinal Bleeding (Occult or Overt)United States
-
Centro Hospitalar de Vila Nova de Gaia/Espinho,...RecruitingObscure Gastrointestinal BleedingPortugal
-
University of CalgaryAlberta Heritage Foundation for Medical Research; Calgary Health RegionCompleted
-
Unity Health TorontoActive, not recruitingGastrointestinal Diseases | Obscure Gastrointestinal Bleeding | Gastrointestinal Bleed | Angiodysplasia IntestineCanada
-
Fondazione Poliambulanza Istituto OspedalieroHospices Civils de Lyon; Fondazione Policlinico Universitario Agostino Gemelli... and other collaboratorsCompletedIron Deficiency Anemia | Obscure Gastrointestinal BleedingItaly
-
Texas Tech University Health Sciences Center, El...RecruitingAnemia, Iron Deficiency | Obscure Gastrointestinal BleedingUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedGastric Antral Vascular Ectasia | Angiodysplasia | Obscure Gastrointestinal Bleeding | Thalidomide